期刊
HUMAN MUTATION
卷 41, 期 9, 页码 1577-1587出版社
WILEY-HINDAWI
DOI: 10.1002/humu.24061
关键词
cardiomyopathy gene panel testing; dilated cardiomyopathy; dilated cardiomyopathy genetics; pediatric cardiomyopathy; risk allele; VCL; vinculin; vinculin loss of function
资金
- MRC [MC_UP_1102/20] Funding Source: UKRI
- NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200359] Funding Source: NIH RePORTER
The ACMG/AMP variant classification framework was intended for highly penetrant Mendelian conditions. While it is appreciated that clinically relevant variants exhibit a wide spectrum of penetrance, accurately assessing and expressing the pathogenicity of variants with lower penetrance can be challenging. The vinculin (VCL) gene illustrates these challenges. Model organism data provide evidence that loss of function ofVCLmay play a role in cardiomyopathy and aggregate case-control studies suggest low penetrance. VCLloss of function variants, however, are rarely identified in affected probands and therefore there is a paucity of family studies clarifying the clinical significance of individual variants. This study, which aggregated data from >18,000 individuals who underwent gene panel or exome testing for inherited cardiomyopathies, identified 32 probands withVCLloss-of-function variants and confirmed enrichment in probands with dilated cardiomyopathy (odds ratio [OR] = 9.01; confidence interval [CI] = 4.93-16.45). Our data revealed that the majority of these individuals (89.5%) had pediatric onset of disease. Family studies demonstrated that heterozygous loss of function ofVCLalone is insufficient to cause cardiomyopathy but that these variants do contribute to disease risk. In conclusion,VCLloss-of-function variants should be reported in a diagnostic setting but need to be clearly distinguished as having lower penetrance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据